Vivos Therapeutics, Inc. (VVOS): Depreciation & Amortization
$1.31M
Year ended 2025-12-31
$1.79M
Trailing 12 months to 2026-06-30
+25.1%
3-year compound annual growth
+12.8%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.31M | +125.3% | 2026-04-15, From 2025-01-01 |
| 2024-12-31 | $581.0K | -6.4% | 2026-04-15, From 2024-01-01 |
| 2023-12-31 | $621.0K | -7.2% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $669.0K | -8.7% | 2024-07-30, From 2022-01-01 |
| 2021-12-31 | $733.0K | +2.1% | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $718.0K | -4.4% | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | $751.2K | n/a | 2021-03-25, From 2019-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | $1.31M | +125.3% |
| Nephros Inc (NEPH) | 2025-12-31 | $140.0K | +3.7% |
| Sonoma Pharmaceuticals, Inc. (SNOA) | 2026-03-31 | $139.0K | +0.7% |
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | $983.0K | -1.4% |
| Baird Medical Investment Holdings Ltd (BDMD) | 2025-12-31 | $1.10M | -3.1% |
| Nexgel, Inc. (NXGL) | 2025-12-31 | $450.0K | +3.2% |
| Sensus Healthcare, Inc. (SRTS) | 2025-12-31 | $400.0K | +100.0% |
| WORK Medical Technology Group LTD (WOK) | 2025-09-30 | $923.1K | -34.6% |
| Medinotec Inc. (MDNC) | 2026-02-28 | $80.9K | +9.5% |
Compare VVOS, NEPH, SNOA, ALUR side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗